OCUPHIRE PHARMA INC's ticker is OCUP and the CUSIP is 67577R102. A total of 36 filers reported holding OCUPHIRE PHARMA INC in Q4 2022. The put-call ratio across all filers is 3.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,876,997 | -25.2% | 858,805 | -3.1% | 0.00% | – |
| Q2 2023 | $3,844,711 | +21.1% | 885,878 | +4.6% | 0.00% | – |
| Q1 2023 | $3,175,133 | +27.9% | 846,702 | +20.4% | 0.00% | – |
| Q4 2022 | $2,482,839 | +75.6% | 703,354 | +0.0% | 0.00% | – |
| Q3 2022 | $1,414,000 | +4.7% | 703,088 | 0.0% | 0.00% | – |
| Q2 2022 | $1,350,000 | -40.7% | 703,088 | 0.0% | 0.00% | – |
| Q1 2022 | $2,278,000 | -13.2% | 703,088 | 0.0% | 0.00% | – |
| Q4 2021 | $2,623,000 | -48.1% | 703,088 | -28.3% | 0.00% | – |
| Q3 2021 | $5,051,000 | +2477.0% | 980,737 | +2540.2% | 0.00% | – |
| Q2 2021 | $196,000 | +148.1% | 37,146 | +170.7% | 0.00% | – |
| Q1 2021 | $79,000 | -15.1% | 13,720 | -4.2% | 0.00% | – |
| Q4 2020 | $93,000 | – | 14,315 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Richmond Brothers, Inc. | 340,526 | $1,276,976 | 2.16% |
| Knoll Capital Management, LLC | 100,000 | $375,000 | 0.58% |
| RICE HALL JAMES & ASSOCIATES, LLC | 809,117 | $3,034,189 | 0.17% |
| Diametric Capital, LP | 55,648 | $208,680 | 0.10% |
| MAI Capital Management | 494,690 | $1,855,088 | 0.03% |
| TRUST CO OF TOLEDO NA /OH/ | 26,000 | $97,500 | 0.02% |
| Bedel Financial Consulting, Inc. | 15,000 | $56,250 | 0.01% |
| Legato Capital Management LLC | 16,456 | $61,710 | 0.01% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 19,623 | $73,586 | 0.01% |
| Cornerstone Capital, Inc. | 16,357 | $61,339 | 0.01% |